FIGO/ICM guidelines for preventing Rhesus disease: A call to action.

{"article_title":"FIGO\/ICM guidelines for preventing Rhesus disease: A call to action.","author":"Visser GHA, Thommesen T, Di Renzo GC, Nassar AH, Spitalnik SL","journal_title":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","issn":"1879-3479","isbn":"","publication_date":"2021-02-01","volume":"152","issue":"2","first_page":"144","page_count":"","accession_number":"33128246","doi":"","publisher":"Wiley","doctype":"Journal Article","subjects":"Rh Isoimmunization immunology; Rho(D) Immune Globulin immunology; Female; Humans; Pregnancy","interest_area":["Obstetrics & Gynecology"," Allergy Immunology & Inflammation"," Pediatric Medicine"],"abstract":"The introduction of anti-Rh(D) immunoglobulin more than 50 years ago has resulted in only a 50% decrease in Rhesus disease globally owing to a low uptake of this prophylactic approach. The International Federation of Gynecology and Obstetrics, International Confederation of Midwives, and Worldwide Initiative for Rhesus Disease Eradication have reviewed current evidence regarding the utility of anti-Rh(D) immunoglobulin. Taking into account the effectiveness anti-Rh(D), the new guidelines propose adjusting the dose for different indications and prioritizing its administration by indication. \u00a9 2021 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=33128246","isPdfLink":true,"isSAML":false,"an":"33128246","number_other":"","type_pub":"","issn_electronic":"1879-3479","languages":"English","language":"eng","date_entry":"","date_update":"","titleSource":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2021 Feb; Vol. 152 (2), pp. 144-147. Date of Electronic Publication: 2021 Jan 09.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2021-02-01","description":"The introduction of anti-Rh(D) immunoglobulin more than 50 years ago has resulted in only a 50% decrease in Rhesus disease globally owing to a low uptake of this prophylactic approach. The International Federation of Gynecology and Obstetrics, International Confederation of Midwives, and Worldwide Initiative for Rhesus Disease Eradication have reviewed current evidence regarding the utility of anti-Rh(D) immunoglobulin. Taking into account the effectiveness anti-Rh(D), the new guidelines propose adjusting the dose for different indications and prioritizing its administration by indication.<br \/> (© 2021 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=33128246&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Visser GHA, Thommesen T, Di Renzo GC, Nassar AH, Spitalnik SL","header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"33128246","RelevancyScore":"886","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"885.599182128906"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=33128246&authtype=shib&custid=ns346513&group=main&profile=eds","physicalDescription":{"Pagination":{"StartPage":"144"}},"additionalInfo":{"Authored_By":"Visser GHA, Thommesen T, Di Renzo GC, Nassar AH, Spitalnik SL","Corporate_Authors":"FIGO Committee for Safe Motherhood, Newborn Health","Journal_Info":"Publisher: Wiley Country of Publication: United States NLM ID: 0210174 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3479 (Electronic) Linking ISSN: 00207292 NLM ISO Abbreviation: Int J Gynaecol Obstet Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline","Published_Date":"2021-02-01","Source":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2021 Feb; Vol. 152 (2), pp. 144-147. Date of Electronic Publication: 2021 Jan 09.","Languages":"English","Electronic_ISSN":"1879-3479","MeSH_Terms":"Rh Isoimmunization\/*immunology , Rho(D) Immune Globulin\/*immunology, Female ; Humans ; Pregnancy","Subjects":"Female, Humans, Pregnancy, Rh Isoimmunization immunology, Rho(D) Immune Globulin immunology","Title_Abbreviations":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","Volume":"152"}}